ROME — Implantation of the Hydrus microstent in combination with cataract surgery or as a stand-alone procedure is a safe, microinvasive treatment of open-angle glaucoma, according to one specialist.
“IOP reduction is significant from the first postoperative day and remains consistent over time,” Magda Rau, MD, said at OSN Italy.
In many patients with glaucoma, maximum medical therapy is still not able to control IOP and halt progressive optic nerve damage. In addition, side effects lead to poor adherence or discontinuation in some cases. Filtration surgery, on the other hand,